HIV-1 Drug Resistance test in Ghatkopar - Metropolis Healthcare
lab image
back-arrow-image Search Health Packages, Tests & More
Home > HIV-1 Drug Resistance test in Ghatkopar
yuth-image

HIV-1 Drug Resistance test in Ghatkopar

17000

17000

HIV-1 Drug Resistance testing is used to evaluate whether a patient with human immunodeficiency virus (HIV) has a mutated form of the virus that does not respond to antiretroviral therapy (ART) as expected. ART involves taking a combination of HIV medicines that can help control the replication of the virus.

Sorry, this test is not available to book.

home image
Blood Collection at Home
report image
Smart Report with Trend Analysis
protocol image
8-stage MET Protocol
certificate image
Certified CAP & NABL Labs

    HIV-1 Drug Resistance testing test along with clinical presentation and other laboratory markers can determine the progress of the disease for the management of HIV-1 infected patients. It is used to evaluate the outcome of a patient’s treatment by calculating the baseline HIV-1 RNA level or by observing the effects of antiretroviral therapy by analyzing changes in EDTA plasma HIV-1 RNA levels during the course of treatment.

    The testing can also assess whether a patient with HIV has a mutated form of the virus that does not respond to antiretroviral therapy. The drug resistance can either be transmitted at the time of HIV infection or acquired during previous treatments. If a patient is failing and not responding to first-line antiretroviral therapy, he/she is referred for HIV-1 Drug Resistance testing before starting the second-line drugs.

    However, it is important to note that this test is not proposed to be used as a screening test for the presence of HIV-1 in blood or as a diagnostic test for confirmation of the HIV-1 infection.

Your doctor can ask you to take HIV-1 Drug Resistance testing if he is planning to switch the medicines from first- to second-line antiretroviral therapy. Switching of medicines and adjustment in the treatment therapy become highly important because if an HIV-infected patient becomes resistant to a drug and keeps on taking the same drug, HIV will multiply faster as the drug will not have the potential to stop it from replicating.

Besides, HIV drug-resistance testing is also advised for the first-time patient entering into the care to guide the selection of the initial antiretroviral drugs regimen, according to the guideline.

HIV is a virus that attacks the immune system, the body's natural defense system, and is of two types;

  • HIV-1 causes almost all cases of AIDS globally.
  • HIV-2 causes an AIDS-like illness, it is generally found in North America.

The drugs which act to stop the replication of the virus are called antiretroviral drugs.

The more commonly used antiretroviral drugs belong to five drug classes: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs) and CCR5 antagonists. It has been shown that the HIV virus is a highly mutatable virus. Alterations in the genetic makeup of the virus can render it immune to a particular class of drug rendering it ineffective as a treatment option.

Studies have shown that failure of first-line antiretroviral drugs has increased the risk of cross-resistance to NRTI. Therefore, patients who failed after multiple NRTI-substitutions on first-line drugs should be referred for HIV-1 Drug Resistance testing before selecting NRTIs for optimum second-line combination drugs.

HIV is a virus that attacks the immune system, the body's natural defense system, and is of two types;

      HIV-1 causes almost all cases of AIDS globally.
      HIV-2 causes an AIDS-like illness, it is generally found in North America.

The drugs which act to stop the replication of the virus are called antiretroviral drugs.

The more commonly used antiretroviral drugs belong to five drug classes: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs) and CCR5 antagonists. It has been shown that the HIV virus is a highly mutatable virus. Alterations in the genetic makeup of the virus can render it immune to a particular class of drug rendering it ineffective as a treatment option.

Studies have shown that failure of first-line antiretroviral drugs has increased the risk of cross-resistance to NRTI. Therefore, patients who failed after multiple NRTI-substitutions on first-line drugs should be referred for HIV-1 Drug Resistance testing before selecting NRTIs for optimum second-line combination drugs.

Ratings & Reviews (0)

No reviews available
basket image
Basket
(0 items) down arrow image

TruHealth Checkups

Find the most suitable checkup for you from our range of TruHealth Checkups

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

lab image
115+ Advanced
Labs
lab image
Trusted by Leading
Doctors & Hospitals
lab image
Over 2000+
Scientific Officers
lab image
Proficiency Testing for
Accurate Reports

Frequently Asked Questions

Yes our laboratory is accredited by the NABL (National Accreditation Board of Testing and Calibration of Laboratories) India & College of American Pathologists (CAP). This accreditation process is carried out every 2 years for NABL & annually for CAP with periodic internal audits carried out twice in a year. All our aforementioned tests are accredited by NABL & CAP.

TruHealth is an expert and comprehensive inner health wellness by Metropolis. It helps you monitor and maintain your inner health parameters better, so that you are ready to achieve your dreams, always.Metropolis TruHealth – Because Health is Everything.

SMART report covers a comprehensive view of your lifestyle related diseases and risk analysis, health recommendations, reminders and recommended reflex tests. Get regular communications to monitor and maintain your inner health.

Reports will be delivered on your registered email id with a TAT (Turnaround time) of 24 hours.

We will deliver reports on your email id, check the email received from Metropolis India. You can also download it by signing in to your profile in our website or in TruHealth App

You can select the best health package suited to you based on your gender, age and lifestyle.

Additional Home Visit and Safety charges will be applicable for all test and Health packages.

We collect samples from home between 7 AM to 11 PM (in Mumbai) and 7 AM to 9 PM in other cities. we offer Blood collection service on Sunday’s as well.

Doctor’s prescription is not required if you avail any wellness package. For any illness test, prescription might be required.

Test samples are processed at our regional laboratories in various cities – Mumbai, Pune, Chennai, Bangalore, Delhi and more. You can check out more information here – Our Labs

Our Blog

Take a look at some of the related content from our blog

What Our Customers Say

We’re satisfying our customers every day since 1980

Our Global Reference Lab

our-lab

Accreditations

certification-1 image
certification-1 image
certification-1 image

HIV-1 Drug Resistance test

17000